Improving quality of life among cancer patients in Malaysia

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 1069-1075

  Ezat, WP Sharifa ^a   Noraziani, K ^a   Sabrizan, O ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Cancer; Health cancer service; Malaysia; Quality of life

Indexed keywords

ARTICLE; GOVERNMENT; HUMAN; MALAYSIA; NEOPLASM; PALLIATIVE THERAPY; QUALITY OF LIFE; TOTAL QUALITY MANAGEMENT;

GOVERNMENT PROGRAMS; HUMANS; MALAYSIA; NEOPLASMS; PALLIATIVE CARE; QUALITY IMPROVEMENT; QUALITY OF LIFE;

EID: 84871683426     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.1069     Document Type: Note

References (54)

1. Bagi CM (2005). Targeting of therapeutic agents to bone to treat metastatic cancer. Adv Drug Delivery Rev, 57, 995-1010.
2. Brennan F, Carr DB, Cousins M (2007). Pain management: a fundamental human right. Anesth Analg, 105, 205-21.
3. Calman KC (1984). Quality of life in cancer patients: a hypothesis. J Med Ethic.s 10, 124-7.
4. Carr AJ, Higginson IJ (2001). Are QOL measures patient centred? Bri Med J, 322, 1357-60.
5. Castellano D, Sepulveda JM, Garcìa-Escobar, et al (2011). The role of rank-ligand inhibition in cancer: the story of Denosumab. The Oncologist, 16, 136-45
6. Chan SC (1999). Practice of breast self-examination amongst women attending a Malaysia Well Person's Clinic. Med J Malaysia, 54, 433-7.
7. Chee HL, Rashidah S, Shamsuddin K, Aharifah Zainiyah SY (2003). Knowledge and Practise of Breast Cancer Examination and Pap Smear Screening Among A Group of Electronic Women Worker. Med J Malaysia, 58, 320-9.
8. Choong LP, Taib NAM, Rampal S, et al (2010). High tumour stage and margin clearance are still important prognostic factors for post-mastectomy locoregional recurrence in Malaysia. Asian Pac J Cancer Prev, 11, 1409-16.
9. Coleman, RE (2004). Bisphosphonates: clinical experience. The Oncologist, 9, 14-27.
10. Decima Research Inc (2002). National Profile of Family Caregivers in Canada. Prepared for Health Canada. http://www.hc-sc.gc.ca/hcs-sss/alt_formats/hpb-dgps/pdf/pubs/2002-caregiv-interven/2002-caregiv-interven-eng.pdf [21 October 2008].
11. Dhillon S, Lyseng-Williamson KA (2008). Zoledronic Acid: A review of its use in the management of bone metastases of malignancy. Drugs, 68, 507-34
12. Doris Padmini Selvaratnam, Norlaila Abu Bakar, Nor Aini Hj Idris (2010) Economic well-being and morbidity of the elderly in Malaysia. J Mod Acc Auditing, 6, 1548-6583
13. Editorial Lancet (1995). Quality of life and clinical trials. The Lancet, 346, 1-2.
14. Eisenberg DM, Kessler RC, Foster C, et al (1993). Unconventional medicine in the United States: Prevalence, cost and patterns of use. N Engl J Med, 328, 246-52.
15. GLOBOCAN (2008) Report. Malaysia. http://globocan.iarc.fr/factsheet.asp. [12 November 2011].
16. Hafslund B, Espehaug B, Nortvedt MW (2011). Effects of false-positive results in a breast screening program on anxiety, depression and health-related quality of life. Cancer Nursing, DOI: 10.1097/NCC.0b013e3182341ddb. http://www.scopus.com/record/display.url?eid [13 November 2011].
17. Hew K, Lim G, Lau FN, et al (1996). Preliminary results of a phase 2 study of docetaxel in the treatment of patients with advanced or metastatic breast cancer in Malaysia. Presented at the 13th Asian Pan Pacific Congress of Medicine, Penang 1996.
18. Hisham AN, Yip CH (2004). Overview of breast cancer in Malaysian women: a problem with late diagnosis. Asian J Surg, 27, 130-3.
19. Koenig HG (2000). Religion, spirituality, and medicine: application to clinical practice. JAMA, 284, 1708.
20. Lee J, Dibble SL, Pickett M, Judith L (2005). Chemotherapy induced nausea-vomiting and functional status in women treated for breast cancer. Cancer Nursing, 28, 249-55.
21. Lei CP, Har YC, Khatijah LA (2011). Informational needs of breast cancer patients on chemotherapy: differences from nurses' perceptions. Asian Pac J Cancer Prev, 12, 797-802.
22. Liang LP, Dunn SM, Gorman A, Stuart-Harris R (1990). Identifying priorities of psychosocial need in cancer patients. Br J Cancer, 62, 1000-3.
23. Lim AKH, Haron MR, Yap TM (1994). Ondansetron against metochlorpramide/ dexamethasone - A comparative study. Med J Malaysia, 49, 231-8.
24. Lim GC & Azura D (2008). National cancer patient registry-a patient registry/clinical database to evaluate the health outcomes of patients undergoing treatment for cancers in Malaysia. Med J Malaysia, 63, 55-6
25. Lim GC (2002) Overview of Cancer in Malaysia. Jpn J Clin Oncol, 32, 37-42
26. Lim GCC (2006). Clinical oncology in Malaysia: 1914 to present. Biomedical Imaging and Intervention Journal, 2(1) art. no. e18 http://www.biij.org/2006/1/e18/e18.pdf [10 November 2011].
27. Lim R (2008). Improving cancer pain management in Malaysia. Oncology, 74, 24-34
28. Mafauzy, M 2000. The problems and challenges of the aging population of Malaysia. Malaysian J Med Sciences, 7, 1-3.
29. Malaysia Health Facts (2010). Ministry of Health Malaysia.
30. Maryam Farooqui, Mohamed A Hassali, Aishah K Shatar et al (2011). A qualitative exploration of Malaysian cancer patients' perspectives on cancer and its treatment. BMC Public Health, 11, 1-8.
31. Ministry of Health Malaysia (2010). Clinical Practice Guideline. Management of Cancer Pain.
32. Ministry of Health Malaysia: The Third National Health & Morbidity Survey Report (2006) Load of Illness. National Institutes of Health, Malaysia
33. Ministry of Health Malaysia (2001). National Policy of Traditional Complementary Medicine Report. http://tcm.moh.gov.my/v4/pdf/NationalPolicy.pdf [ 22 November 2011].
34. Möller A & Sartipy U (2011). Predictors of postoperative quality of life after surgery for lung cancer. J Thoracic Oncol, 17, 406-11.
35. Molassiotis A, Browall M, Milovics L, et al (2006). Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecological Cancer, 16, 21924.
36. Morgan C, Wagstaff J (2009). Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases? Acta Oncologica, 48, 882-9.
37. Natilia Ahmad (2005). Cancer Diagnostic/Therapy Equipment. CS Market Research. National Cancer Patient Registry. 2011. http://www.acrm.org.my/ncpr/default.asp?page=/nc pr/faq.
38. Norzareen M & Nobaya A (2010).Women of the sandwich generation in Malaysia. Eur J Social Sciences, 13, 171-8
39. Ögce, F, Özkan S (2008) Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer. Asian Pac J Cancer Prev, 9, 449-52.
40. Pergolizzi J, Böger RH, Budd K, et al (2008). Opioids and chronic severe pain in the elderly. Pain Practice, 8, 287-313.
41. Poi PJH, Forsyth DR, Chan DKY (2004). Services for older people in Malaysia: issues and challenges. Age Ageing J, 33, 444-6.
42. Priscilla D, Hamidin A, Azhar MZ, et al (2011). Quality of life among patients with heamatological cancer in a Malaysian Hospital. Med J Malaysia, 66 (2):117-120
43. Rosemawati A, Sallehudin AB (2001). Cancer Registration in Malaysia. Asian Pac J Cancer Prev, 2 (IARC Suppl), 43-5.
44. Rowland JH, Mariotto A, Alfano, CM, et al (2011). Survivors: United States, 2007. Morbidity and Mortality Weekly Report. 60(9):269-272. Centers for Disease Control and Prevention. http://www.medscape.com/viewarticle/739375. [1 November 2011]
45. Rushdan MN (2008). Current status and future direction of cervical cancer prevention program in Malaysia report. http://site.obgynanrush.com/clients/obgynanrush/Downloads/Cervical_Cancer_Prevention_in_Malaysia_by_Rushdan_for_OGSM_web11202008122411PM.pdf. [17 February 2012].
46. Saggini R, Calvani M, Bellomo RG, Saggini A (2008). Rehabilitation in cancer survivors: interaction between lifestyle and physical activity. Eur J Inflamm, 6, 99-104.
47. Saidatul NB & Rohani J (2010). Introduction of National HPV Immunisation Program Sharing Malaysia's. Global Meeting on Cervical Cancer Prevention Program, New York.
48. Schipper H, Clinch J, McMurray A, Levitt M (1984) .Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol, 2, 472-83.
49. Sehbai A (2008). Denosumab: are we making progress in treating cancer-related bone metastasis?. Community Oncol, 5, 293-4.
50. Tang TS & Devi B (1996). Early Cancer Surveillance Programme in Sarawak. Proceedings of the 13th Asia Pacific Cancer Conference.
51. Testa MA, Lenderking WR (1992). Interpreting pharmacoeconomic and quality of life clinical trial data for use in therapeutics. Pharmacoeconomics, 2, 107-17.
52. Testa MA, Simonson DC (1996). Assessment of quality-of life outcomes. N Engl J Med, 334, 835-40.
53. Win T, Sharples L, Wells FC, et al (2005). Effect of lung cancer surgery on quality of life. Thorax, 60, 234-8.
54. World Health Organisation (2010). World Health Organisation - Western Pacific Region: Malaysia - country context. http://www.wpro.who.int/countries/maa/ [20 October 2011]